Patents
in sentence
242 examples of Patents in a sentence
In the 1970s, India abolished pharmaceutical patents, creating an advanced and efficient generics industry capable of providing affordable medicines to people throughout the developing world.
That changed in 2005, when the WTO’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) forced India to allow drug
patents.
The Indian government’s desire to enhance its trade relations with the US thus provides the industry an ideal opportunity to pick up where TRIPS left off, by compelling India to make
patents
easier to obtain and to reduce the availability of low-cost generics.
As it stands, India sets the bar quite high, resulting in its refusal to grant
patents
for new combinations of existing drugs.
Because
patents
are essentially government-granted monopolies, they lead to the same inefficiencies and rent-seeking behavior as any other such market distortion.
Furthermore, patent-supported research encourages secrecy, as companies disclose only the information needed to acquire
patents.
Given increasing globalization of business activity; the rising importance of intangible capital that is difficult to price and easy to move (for example,
patents
and brands); competitive cuts in national corporate tax rates; and the spread of tax havens, income shifting and the resulting tax-base erosion have become a major policy concern throughout the OECD.
Support for basic research, and
patents
to protect successful innovation, may help.
Moreover, so-called “patent thickets” – the fear that some advance will tread on pre-existing patents, of which the innovator may not even be aware – may also discourage innovation.
For example, immigrants to the US contribute more than half of the
patents
and Silicon Valley start-ups.
My own research, carried out with Zhuan Xie and Xiaobo Zhang, shows that Chinese firms – especially in the private sector – have lately accelerated innovation, and are being awarded an increasing number of
patents
at home and abroad.
Doing Well by Doing GoodWASHINGTON, DC – Two years ago, Tesla CEO Elon Musk decided to open access to his company’s
patents
to anyone – a move that ran completely counter to traditional competitive behavior.
If Tesla’s open
patents
succeed in bringing other players into the sector, it could transform what is now a niche product into a mass-market phenomenon – a transformation that would significantly advance the fight against climate change.
It retains a highly innovative economy, which registers more new
patents
each year than all European countries combined – second only to the US and eons ahead of China and India.
In the US and many other developed countries, the average cost of bringing a new drug to market has skyrocketed, even as
patents
on some of the industry’s most profitable drugs have expired.
So Big Pharma is seeking “incentives” to pursue research and development of new antibiotics, such as extended
patents
or tax breaks; the alternative would be to charge astronomical prices for new drugs.
If the company’s processes offer all of the benefits that it claims, I hope that its founders license their
patents
broadly over time.
Frankly, when I think of stagnating innovation as an economist, I worry about how overweening monopolies stifle ideas, and how recent changes extending the validity of
patents
have exacerbated this problem.
Data concerning
patents
documents America's advantage: in the late 1990s 56% of all global
patents
in high-tech fields was granted to US applicants, only 11% to EU applicants.
With 1,780 patent applications, California accounted for 15% of all
patents
sought by MENA-linked inventors worldwide.
From 2000 to 2010, it had eight times more
patents
filed by an immigrant (194,600) than its closest competitor, Germany (25,300).
Do
patents
stimulate or impede innovation?
That is why
patents
expire.
Today Japan ranks first in the world in the number of patents, third in expenditure on research and development as a share of GDP, second in book sales and music sales, and highest for life expectancy.
And, since 2013, the UK has applied a special tax rate on income from patents, which will fall gradually to 10% by 2017.
So we invested in education and science, and today we have the world’s highest percentage of scientists and
patents
per capita.
In recent years, however, patent law widened enormously with the acceptance, in the United States, Australia, Japan, and Korea, of business-method
patents
--that is,
patents
not on a technological process but on a way of doing business.
The expanding scope of
patents
increases their value as a tool to promote creativity.
While previously most patentable inventions were produced in laboratories, with business-method
patents
the rewards for creativity can now motivate all kinds of people throughout a business organization.
Indeed, countries that do not allow business-method patents--even though some of their citizens apply for
patents
in the US--run the risk that their businesses will lose some of their creative edge.
Back
Related words
Which
Their
Research
Companies
Patent
Innovation
Drugs
Countries
Pharmaceutical
Could
Other
Number
World
Property
Intellectual
Would
There
Should
Rights
Market